NexgenRX Inc. (NXG) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.106x

Based on the latest financial reports, NexgenRX Inc. (NXG) has a cash flow conversion efficiency ratio of 0.106x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$880.82K ≈ $637.17K USD) by net assets (CA$8.29 Million ≈ $6.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NexgenRX Inc. (NXG) market capitalisation for the company's overall valuation and market capitalisation.

NexgenRX Inc. - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how NexgenRX Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

NexgenRX Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NexgenRX Inc. ranked by their cash flow conversion efficiency. Explore NXG cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Cubic Digital Technology Co Ltd SHE:300344	-0.061x
Chin Yang Chem KO:051630	-0.010x
Naos Emerging Opportunities Company Ltd AU:NCC	0.055x
Sphere 3D Corp NASDAQ:ANY	-0.373x
Rubicon Organics Inc V:ROMJ	0.050x
Nara Mold & Die Co. Ltd KQ:051490	-0.010x
Sungwoo Electronics Co. Ltd KQ:081580	0.054x
Grand House Mulia Pt JK:HOMI	0.019x

Annual Cash Flow Conversion Efficiency for NexgenRX Inc. (2013–2024)

The table below shows the annual cash flow conversion efficiency of NexgenRX Inc. from 2013 to 2024. View current stock price of NexgenRX Inc. for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$7.62 Million ≈ $5.52 Million	CA$1.15 Million ≈ $832.04K	0.151x	-8.88%
2023-12-31	CA$7.71 Million ≈ $5.58 Million	CA$1.28 Million ≈ $924.01K	0.166x	+37.46%
2022-12-31	CA$8.85 Million ≈ $6.40 Million	CA$1.07 Million ≈ $771.17K	0.120x	-69.41%
2021-12-31	CA$9.71 Million ≈ $7.03 Million	CA$3.82 Million ≈ $2.77 Million	0.394x	-18.05%
2020-12-31	CA$5.52 Million ≈ $3.99 Million	CA$2.65 Million ≈ $1.92 Million	0.480x	-15.42%
2019-12-31	CA$1.84 Million ≈ $1.33 Million	CA$1.05 Million ≈ $756.44K	0.568x	+319.14%
2018-12-31	CA$1.96 Million ≈ $1.42 Million	CA$-507.38K ≈ $-367.03K	-0.259x	-97.65%
2017-12-31	CA$1.96 Million ≈ $1.42 Million	CA$-257.35K ≈ $-186.16K	-0.131x	-120.25%
2016-12-31	CA$758.06K ≈ $548.37K	CA$490.96K ≈ $355.16K	0.648x	+55.58%
2015-12-31	CA$-83.93K ≈ $-60.71K	CA$-34.94K ≈ $-25.27K	0.416x	-65.35%
2014-12-31	CA$-464.55K ≈ $-336.05K	CA$-558.18K ≈ $-403.78K	1.202x	+105.71%
2013-12-31	CA$-36.81K ≈ $-26.63K	CA$774.08K ≈ $559.95K	-21.026x	--

About NexgenRX Inc.

V:NXG Canada Health Information Services

Market Cap

$30.87 Million

CA$42.67 Million CAD

Market Cap Rank

#24701 Global

#946 in Canada

Share Price

CA$0.60

Change (1 day)

-1.64%

52-Week Range

CA$0.31 - CA$0.70

All Time High

CA$0.70